Update on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinib

Chronic myelogenous leukemia (CML) is a pluripotent stem cell disease characterized by the presence of the Philadelphia chromosome and the bcr-abl gene. The discovery of tyrosine kinase inhibitors (TKIs) revolutionized therapy for CML, such that durable response, increased overall survival, and incr...

Descripción completa

Detalles Bibliográficos
Autores principales: Emole, Josephine, Talabi, Taiwo, Pinilla-Ibarz, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777272/
https://www.ncbi.nlm.nih.gov/pubmed/27013862
http://dx.doi.org/10.2147/BTT.S67844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777272/
https://www.ncbi.nlm.nih.gov/pubmed/27013862
http://dx.doi.org/10.2147/BTT.S67844

Ejemplares similares